Added to YB: 2026-04-16
Pitch date: 2026-04-14
SNWV [neutral]
SANUWAVE Health, Inc.
+3.4%
current return
Author Info
The Clinical Edge researches and shares thesis-driven ideas on potential healthcare multibaggers. Sign up for the newsletter.
Company Info
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures.
Market Cap
$148.1M
Pitch Price
$17.67
Price Target
N/A
Dividend
N/A
EV/EBITDA
20.91
P/E
42.23
EV/Sales
3.61
Sector
Health Care Equipment and Supplies
Category
turnaround
SANUWAVE Q4 2025: Record Revenue, Record Systems, and an Industry Shockwave
SNWV (update): Down 50% to $17.50 since Aug despite record FY25: $44.1M rev (+35%), $13.6M adj EBITDA (vs $7.2M), 77% gross margin, 624 systems sold. Missed $48-50M guide. CMS cut skin substitute reimbursement 90-95%, causing customer churn—Q4 consumables decel to +10.6% from +27% FY. 168 systems discontinued Q4. 2026 guide now 16-25% growth vs prior 50%+. Watching Q1 consumables, reseller traction, H2 accel.
Read full article (3 min)